Insider Sale: Chief Experience Officer of $ALHC (ALHC) Sells 35,000 Shares
Insider Sale: Chief Experience Officer of $ALHC (ALHC) Sells 35,000 Shares
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.Hakan Kardes, the Chief Experience Officer of $ALHC ($ALHC), sold 35,000 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.8% of their shares. Following this trade, they now own 320,444 shares of $ALHC stock.
致富金融(臨時代碼)的首席體驗官Hakan Kardes在2024年11月27日出售了公司的35,000股股票。我們從最近的SEC文件中獲得了此交易數據。這次交易大約佔據了他們股份的9.8%。在此交易之後，他們現在擁有320,444股$ALHC股票。
$ALHC Insider Trading Activity
$ALHC 內部交易活動
$ALHC insiders have traded $ALHC stock on the open market 61 times in the past 6 months. Of those trades, 0 have been purchases and 61 have been sales.
$ALHC內部人士在過去6個月裏已經在公開市場上交易了61次$ALHC股票。在這些交易中，有0次購買和61次銷售。
Here's a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
以下是過去6個月內部人士對 $ALHC 股票的近期交易詳情：
- HAKAN KARDES (Chief Experience Officer) has traded it 5 times. They made 0 purchases and 5 sales, selling 110,000 shares.
- DAWN CHRISTINE MARONEY (President, Markets) has traded it 13 times. They made 0 purchases and 13 sales, selling 280,000 shares.
- ROBERT THOMAS FREEMAN (Chief Financial Officer) has traded it 17 times. They made 0 purchases and 17 sales, selling 426,500 shares.
- JOHN E KAO (Chief Executive Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 270,000 shares.
- JOSEPH S KONOWIECKI has traded it 8 times. They made 0 purchases and 8 sales, selling 123,333 shares.
- HYONG KIM (Chief Medical Officer) sold 22,460 shares.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has traded it 11 times. They made 0 purchases and 11 sales, selling 74,467 shares.
- JEFFREY H MARGOLIS has traded it 3 times. They made 0 purchases and 3 sales, selling 3,600 shares.
- 首席體驗官HAKAN KARDES已經交易過5次。他們進行了0次購買和5次銷售，總共賣出了110,000股。
- 市場總裁DAWN CHRISTINE MARONEY已經進行了13次交易。他們進行了0次購買和13次銷售，總計賣出了280,000股。
- ROBERt THOMAS FREEMAN（首席財務官）交易了17次。他們進行了0次買入和17次賣出，賣出了426,500股。
- JOHN E KAO（首席執行官）交易了3次。他們進行了0次買入和3次賣出，賣出了270,000股。
- JOSEPH S KONOWIECKI 交易了8次。他們進行了0次買入和8次賣出，賣出了123,333股。
- HYONG KIm (首席醫療官) 賣出了22,460股。
- CHRISTOPHER J JOYCE (首席法律和行政官) 共交易了11次。他們沒有進行購買，進行了11次賣出，賣出了74,467股。
- JEFFREY H MARGOLIS 共交易了3次。他們沒有進行購買，進行了3次賣出，賣出了3,600股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟蹤內部交易，請查看Quiver Quantitative的內部交易特斯拉-儀表。
$ALHC Hedge Fund Activity
$ALHC對沖基金活動
We have seen 73 institutional investors add shares of $ALHC stock to their portfolio, and 77 decrease their positions in their most recent quarter.
我們看到73家機構投資者在他們最近的一個季度中增加了 $ALHC 股票的持股量，而另有77家減少了他們的持倉。
Here are some of the largest recent moves:
以下是一些最近最大的交易動態：
- WARBURG PINCUS LLC removed 4,300,000 shares (-24.0%) from their portfolio in Q3 2024
- 8 KNOTS MANAGEMENT, LLC added 2,446,968 shares (+inf%) to their portfolio in Q3 2024
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,443,795 shares (-30.4%) from their portfolio in Q3 2024
- DURABLE CAPITAL PARTNERS LP added 1,495,879 shares (+37.6%) to their portfolio in Q3 2024
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,258,648 shares (+2403.5%) to their portfolio in Q3 2024
- CITADEL ADVISORS LLC removed 1,257,276 shares (-100.0%) from their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 1,227,782 shares (-71.4%) from their portfolio in Q3 2024
- 華堡平卡斯有限責任公司在2024年第三季度從其投資組合中移除了4,300,000股(-24.0%)。
- 8節管理有限責任公司在2024年第三季度向其投資組合中增加了2,446,968股(+inf%)。
- 普信集團投資管理公司在2024年第三季度從其投資組合中移除了2,443,795股（-30.4%）。
- 耐用資本合作伙伴有限合夥公司在2024年第三季度向其投資組合中增加了1,495,879股(+37.6%)。
- Price t Rowe Associates Inc /MD/在2024年第三季度向其投資組合新增了1,258,648股（+2403.5%）。
- 城堡顧問有限責任公司在2024年第三季度從其投資組合中移除了1,257,276股(-100.0%)。
- 千禧年管理有限責任公司在2024年第三季度從其投資組合中移除了1,227,782股(-71.4%)。
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要追蹤對沖基金的股票組合，請查看Quiver Quantitative的機構持股儀表板。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不構成金融建議。有關Quiver Quantitative的免責聲明，請查看更多信息。
